Farmers & Merchants Investments Inc’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-218
Closed -$9.4K 1821
2024
Q1
$9.4K Hold
218
﹤0.01% 655
2023
Q4
$9.07K Hold
218
﹤0.01% 656
2023
Q3
$8.67K Hold
218
﹤0.01% 647
2023
Q2
$8.94K Hold
218
﹤0.01% 660
2023
Q1
$8.94K Hold
218
﹤0.01% 646
2022
Q4
$8.93K Hold
218
﹤0.01% 678
2022
Q3
$9K Hold
218
﹤0.01% 664
2022
Q2
$9K Hold
218
﹤0.01% 744
2022
Q1
$10K Hold
218
﹤0.01% 759
2021
Q4
$10K Hold
218
﹤0.01% 768
2021
Q3
$10K Hold
218
﹤0.01% 744
2021
Q2
$11K Hold
218
﹤0.01% 632
2021
Q1
$11K Buy
218
+92
+73% +$4.9K ﹤0.01% 601
2020
Q4
$7K Hold
126
﹤0.01% 710
2020
Q3
$5K Hold
126
﹤0.01% 733
2020
Q2
$5K Hold
126
﹤0.01% 729
2020
Q1
$5K Hold
126
﹤0.01% 679
2019
Q4
$6K Hold
126
﹤0.01% 728
2019
Q3
$4K Hold
126
﹤0.01% 784
2019
Q2
$5K Hold
126
﹤0.01% 750
2019
Q1
$5K Buy
+126
New +$5.12K ﹤0.01% 742

Other funds holding XPH

Farmers & Merchants Investments Inc's XPH Position: Q2 2024 in Review

Farmers & Merchants Investments Inc sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2024, closing a stake of 218 shares — an estimated $9.4K sold.

Farmers & Merchants Investments Inc first reported a position in XPH in Q1 2019 and held it in 21 quarters. The position peaked at $11K in Q2 2021. 71 funds tracked by Wall St. Rank hold XPH as of Q2 2024.

  • Farmers & Merchants Investments Inc reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2024 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 218 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2024, an estimated $9.4K.
  • Farmers & Merchants Investments Inc first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2019 and held it in 21 quarters.
  • Farmers & Merchants Investments Inc's State Street SPDR S&P Pharmaceuticals ETF position peaked at $11K in Q2 2021.
  • 71 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2024.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2024, filed 5 Aug 2024.